Wogonin is a dihydroxy- and monomethoxy-flavone in which the hydroxy groups are positioned at C-5 and C-7 and the methoxy group is at C-8.
定義
Wogonin is a dihydroxy- and monomethoxy-flavone in which the hydroxy groups are positioned at C-5 and C-7 and the methoxy group is at C-8. It has a role as an antineoplastic agent, an angiogenesis inhibitor, a cyclooxygenase 2 inhibitor and a plant metabolite. It is a monomethoxyflavone and a dihydroxyflavone. It is a conjugate acid of a wogonin(1-).
出典: PubChem
米国FDA 物質登録 · UNII POK93PO28W · 登録名 WOGONIN · 単一の化学物質
化粧品での役割
髪や肌の色を抜くBLEACHING
詳しい資料 — 表示名・識別番号・物性・試験記録・文献
別名・識別情報
WOGONININCI
- CAS No.化学物質登録番号
- 632-85-9
- DTXSID米国EPA化学物質番号
- DTXSID70212557
- DTXCID米国EPA化合物番号
- DTXCID00135048
- IUPAC
- 5,7-Dihydroxy-8-methoxy-2-phenyl-4H-1-benzopyran-4-one
- 分子式
- C16H12O5
- 分子量
- 284.267 g/mol
製品が実際に使っている用途
関連文献
- Wogonin as a potential therapeutic agent for psoriasis: Core target identification and validation · 2026
- Wogonin ameliorates the proliferation, inflammatory response, and pyroptosis in keratinocytes via NOD‐like receptor family pyrin domain containing 3/Caspase‐1/Gasdermin‐D pathway · 2024
- Topical Application of Wogonin Provides a Novel Treatment of Knee Osteoarthritis · 2020
- Wogonin suppresses proliferation and invasion of skin epithelioid carcinoma cells through Notch1. · 2020
- Wogonin inhibits the proliferation and invasion, and induces the apoptosis of HepG2 and Bel7402 HCC cells through NF‑κB/Bcl-2, EGFR and EGFR downstream ERK/AKT signaling. · 2016